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AS prosthetic valvea;~~~car~~;~~ (PVE) remains 
a definite risk 
rophylactic 
replacement, 
% 
antibiotics are recommended before 
iagnoatic or therapeutic procedures that ma 
cause transient 
such pro hylaxis, 
E 
bagkt&zza. Effectiveness 0 Y 
has been 
proved c inically. We s&died 533n~~$ecutive 
patie;;To p) 
a 
% 
6 
in our out 
of 24 
- atient department over 
R mont s in whom antibiotic 
P 
rop ylaxis had been recommended according to 
he American Heart Association guidelines. In 
229 of these p 287 procedures were performed 
after administration of a correct 
In none of these p a PVE % 
rophylaxie. 
occurre .
reactions were seen. 
No drug 
with 390 procedures 
In the remaining 304 p 
antibiotics were 
requiring prophylaxis, no 
given. The incident of PVE in 
this group was 1.54 per 100 procedures (n - 6). 
All six had to be re-operated with one 
operative eath. % Incidences for PVE per 100 
% 
rocedures were calculated to be 1.7 
ental procedures, 2.2 per l;tO E 
er.100 
interventions, 2.6 
gyneco oglcal 
surgical proce;z;;s per and 5.1 per 
oropharyn eal 
100 urolog cal s 
procedures. PVE cases in the dental 
surgery group occurred after tooth extraction. 
Streptococci and enterococci were identified as 
causative organisms in the six PVE cases. We 
conclude that the present stud gives evidence 
for the effectiveness of antibio ic +I prophylaxis 
in p with prosthetic heart valves who are at 
high risk for bacterial endocarditis following 
diagnostic and therapeutic procedures. 
ROLE OF PLATELETS IN INFECTIVE ENDOCARDITIS 
ITR AND WITHOUT VEGETATION FORMATION 
Sven Rohmann, Peter Jensen, Harald Darius, Thomas 
Makowski, Raimund Erbel, Jiirgen Meyer 
II. Medical Clinic Gutenberg-University, Mainz FRG 
Complications in infective endocarditis aremore com- 
mon in patients with echocardiographically discerni- 
ble vegetations (KC) anr! more likely when VEG are 
large (> 10 mm in diameter). To assess whether 
platelets contribute to VEG formation, we measured 
platelet aggregation (PAG) in 30 patientspriortothe 
transesophageal echocardiographic examination. PAG 
was stimulated with ADP and the half maximal 
aggregation concentration determined (ED,,,pM+SD), as 
well as the half maximal inhibitory effect (IC,,nM?SD) 
of Iloprost. ED,,and I&were correlatedwithpresence 
(VEG+) or abscence (VEG-1 of VEG attached to aortic 
or mitral valves. The groups were subdivided whether 
N: (VEG+/BC+)=8; (VEG-/BCt)=6;(VEGt/BC-)=7;(VEG-/BC-)=9 
l p < .05 when compared to VEG- and BC- 
No linear correlation was found between EDS,/IC,. and 
VEG size (r=-0.36/0.16), but EDS, was significantly 
1owerinpatientswithlargeVEGwhencomparedtothos.e 
with small VEG (0.71k.10 vs 1.2k.14, respectively). 
We conclude bacterial sepsis increases PAG, which may 
contribute to vegetation formation. In patients with 
negativebloodculturesandVEGPAGis still elevated, 
which might reflect an ongoing platelet activation. 
Normalizing PAG in infective endocarditis may limit 
VEGfonnationandresultinpreservedvalveintegrity. 
FACTORS THAT LIMIT EXERCISE TOLERANCE IN SEVERE 
MITRAL STENOSIS 
Nieca Goldberg M.D., Roseann Chesler, Donald 
Michielli PhD, Richard Stein 
SUNY Health Science Center, Brooklyn, N.Y. 
We studied factors limiting exercise (eX.) 
tolerance in 6 patients (pts) with severe 
mitral stenosis (MS). The valve area=.98+.21& 
by pressure l/2 time. Pts were in sinus rhythm, 
on diuretics only and had "puren S (by cath and 
echo). 
group. 2D targeted mode echo ventricular 
dimensions (EDD, ESD, SD=EDD-ESD, and SD/EDD) 
and analysis of expired air for VO2, R, and 
VO2/HFt(O2 puls 
and at peak du 
bicycle ergome 
MS pts had reduced ex. tolerance (V02peak = 
13.8k3.2 in MS and 36.2k6.3 
with a fall (Pc.05) in E 
ml/kg/min in nls) 
increase in SD/EDD and a 
EDD was unchanged and SD 
significantly increased. proached 1 in MS 
pts (.97f.l1) and exceede in nls. 02 pulse 
increased (Pe.05) to the same extent in both. 
Limited ex. tolerance in 
with a falling EDV and failure to increase 
ejection fraction sufficient to increase stroke 
volume. Increase in 02 pulse in the MS pt thus 
reflects enhanced 02 extraction in re'sponse to a 
relatively reduced cardiac output. R thus 
approaches 1 at low work and V02 levels. 
FIBRINOLYTIC TREATMENT FOR PROSTHETIC HEART 
VALVE THROMBOSIS : EARLY AND LONG TERM RESULTS 
EXPERIENCE WITH 55 PATIENTS 
Raymond ROUDAUT, Thierry LABBE, FranGoise 
LORIENT ROUDAUT, Veronique BOURDENX, Pierre 
BESSE, Michel BOISSEAU, Modeste DALLOCCHIO 
HBpital Cardiologique-CHU de BORDEAUX 
33604 PESSAC-FRANCE 
Fifty five patients (pts 1, were initialy 
treated by fibrinolysis for prosthetic heart 
valve thrombosis during a 10 years period (32 
mitral valve, 22 aortic valve, 
valve) Immediate results 
1 tricuspid 
: fibrinolysis was 
entirely successful in 42 pts (76%3, failure 
of thrombolysis was observed in 13 pts, leading 
to an emergency surgery in 7 pts, 6 pts died 
(4 stroke, 1 cardiac arrrest,l hemorrhage). 
in 
Medium and long term follow up was studied 
40 pts surviving and non reoperated after 
their initial thrombosis. 
at 5 f 1 years, 
22 pts are alive 
diseases, 
6 pts died from extracardiac 
and 12 pts showed thrombosis re- 
currence (7 mitral valve, 5 aortic valve). 
In conclusion, fibrinolytic treatment seems 
to be an attractive alternative for prosthetic 
heart valve thrombosis, particularly for 
critically ill patients. However, initial 
embolic rate is 20% high, with 
permanent damage ; 
possible 
and late recurrence occur 
in 30 % of our patients. 
